Viking Therapeutics Inc
VKTX35.190USD
+1.240+3.65%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
3.96BMarket Cap
LossP/E TTM
Viking Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.01
-10.77%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.008, with a year-on-year change of -10.77%.
What is the net income of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its net income was -109.96M, with a year-on-year change of -28.02%.
What is the net margin of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -17.90%, with a year-on-year change of 48.56%.
What is the Return on Assets (ROA) of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -17.22%, with a year-on-year change of 46.16%.
What is the operating profit of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its operating profit was -150.92M, with a year-on-year change of -49.68%.
What are the current assets of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its current assets were 907.22M, with a year-on-year change of 147.05%.
What are the total assets of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its total assets of Viking Therapeutics Inc were 908.32M, with a year-on-year change of 146.50%.
What are the total liabilities of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its total liabilities of Viking Therapeutics Inc were 28.04M, with a year-on-year change of 39.72%.
What is the total equity of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its total equity of Viking Therapeutics Inc was 880.28M, with a year-on-year change of 152.65%.
What is the net operating income of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its net operating income of Viking Therapeutics Inc was -109.96M, with a year-on-year change of -28.02%.
What is the net investment of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its net investment of Viking Therapeutics Inc was -553.37M, with a year-on-year change of -208.99%.
What is the net financing of Viking Therapeutics Inc?
According to Viking Therapeutics Inc's FY2024 earnings report, its net financing of Viking Therapeutics Inc was 612.46M, with a year-on-year change of 125.69%.
